229 related articles for article (PubMed ID: 32997870)
41. Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis.
Fujiwara K; Fukuda Y; Seza K; Saito M; Yasui S; Nakano M; Yokosuka O; Kato N
Hepatol Int; 2018 Mar; 12(2):191-199. PubMed ID: 29450869
[TBL] [Abstract][Full Text] [Related]
42. Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America.
Enke T; Livingston S; Rule J; Stravitz T; Rakela J; Bass N; Reuben A; Tujios S; Larson A; Sussman N; Durkalski V; Lee W; Ganger D
Liver Transpl; 2023 Jun; 29(6):570-580. PubMed ID: 36825579
[TBL] [Abstract][Full Text] [Related]
43. Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa.
Yassin S; De Lacy R; Pillay K; Goddard E
J Trop Pediatr; 2020 Aug; 66(4):448-457. PubMed ID: 31943108
[TBL] [Abstract][Full Text] [Related]
44. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
45. Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome.
Di Giorgio A; Hadzic N; Dhawan A; Deheragoda M; Heneghan MA; Vergani D; Mieli-Vergani G; Samyn M
J Pediatr; 2020 Mar; 218():121-129.e3. PubMed ID: 31955873
[TBL] [Abstract][Full Text] [Related]
46. Liver transplantation for autoimmune hepatitis: a long-term pathologic study.
Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Hepatology; 2000 Aug; 32(2):185-92. PubMed ID: 10915722
[TBL] [Abstract][Full Text] [Related]
47. Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list.
Ruiz P; Sastre L; Crespo G; Blasi A; Colmenero J; García-Valdecasas JC; Navasa M
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489255
[TBL] [Abstract][Full Text] [Related]
48. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.
Miyagawa-Hayashino A; Haga H; Egawa H; Hayashino Y; Sakurai T; Minamiguchi S; Tanaka K; Manabe T
Transplantation; 2004 Jul; 78(1):128-35. PubMed ID: 15257051
[TBL] [Abstract][Full Text] [Related]
49. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
Joshita S; Yoshizawa K; Umemura T; Ohira H; Takahashi A; Harada K; Hiep NC; Tsuneyama K; Kage M; Nakano M; Kang JH; Koike K; Zeniya M; Yasunaka T; Takaki A; Torimura T; Abe M; Yokosuka O; Tanaka A; Takikawa H;
J Gastroenterol; 2018 Sep; 53(9):1079-1088. PubMed ID: 29476251
[TBL] [Abstract][Full Text] [Related]
50. The clinical phenotypes of autoimmune hepatitis: A comprehensive review.
Wang Q; Yang F; Miao Q; Krawitt EL; Gershwin ME; Ma X
J Autoimmun; 2016 Jan; 66():98-107. PubMed ID: 26614611
[TBL] [Abstract][Full Text] [Related]
51. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.
Biewenga M; Verhelst XPDMJ; Baven-Pronk MAMC; Putter H; van den Berg AP; van Nieuwkerk KCMJ; van Buuren HR; Bouma G; de Boer YS; Simoen C; Colle I; Schouten J; Sermon F; van Steenkiste C; van Vlierberghe H; van der Meer AJ; Nevens F; van Hoek B;
United European Gastroenterol J; 2021 Jul; 9(6):662-671. PubMed ID: 34165262
[TBL] [Abstract][Full Text] [Related]
52. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
[TBL] [Abstract][Full Text] [Related]
53. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
[No Abstract] [Full Text] [Related]
54. Optimizing management in autoimmune hepatitis with liver failure at initial presentation.
Potts JR; Verma S
World J Gastroenterol; 2011 Apr; 17(16):2070-5. PubMed ID: 21547124
[TBL] [Abstract][Full Text] [Related]
55. Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
Martínez Casas OY; Díaz Ramírez GS; Marín Zuluaga JI; Santos Ó; Muñoz Maya O; Donado Gómez JH; Restrepo Gutiérrez JC
Gastroenterol Hepatol; 2018 Nov; 41(9):544-552. PubMed ID: 30017212
[TBL] [Abstract][Full Text] [Related]
56. Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy.
Muratori P; Lalanne C; Barbato E; Fabbri A; Cassani F; Lenzi M; Muratori L
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):139-46. PubMed ID: 26192146
[TBL] [Abstract][Full Text] [Related]
57. Prognosis of probable autoimmune hepatitis patients: a single-center study in Japan.
Fujita K; Oura K; Tadokoro T; Nakahara M; Tani J; Morishita A; Kobara H; Tsutsui K; Himoto T; Masaki T
Intern Emerg Med; 2021 Nov; 16(8):2155-2162. PubMed ID: 33783693
[TBL] [Abstract][Full Text] [Related]
58. De novo autoimmune hepatitis after liver transplantation.
Guido M; Burra P
Semin Liver Dis; 2011 Feb; 31(1):71-81. PubMed ID: 21344352
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.
Ferre-Aracil C; Riveiro-Barciela M; Trapero-Marugán M; Rodríguez-Perálvarez M; Llovet LP; Téllez L; Sánchez-Torrijos Y; Díaz-Fontenla F; Salcedo-Plaza M; Álvarez-López P; de la Mata M; Londoño MC; Bañares-Cañizares R; Calleja JL
Dig Dis Sci; 2021 Aug; 66(8):2826-2832. PubMed ID: 32860579
[TBL] [Abstract][Full Text] [Related]
60. Autoimmune Hepatitis in Children.
Pathak S; Kamat D
Pediatr Ann; 2018 Feb; 47(2):e81-e86. PubMed ID: 29446799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
